Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06723067 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
A NA study of Premature Birth, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06723067: Recruiting NA study of Premature Birth, sponsored by University of Texas at Austin.
NCT06723067 is a NA study of Premature Birth that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 30 participants, below the 393-participant average among 38 other Premature Birth trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06723067, a NA study of Premature Birth, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized controlled trial of impact of wearable, wireless breast pumps on how often and how much milk mothers of premature infants can pump.
Primary Outcome
Number of milk pumping sessions per day
Conditions Studied
Interventions
- DEVICE Wearable wireless breast pump
Study Locations (1)
Texas
- Ascension Seton Medical Center - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-06-12 |
| Est. Completion | 2025-06 |
| Phase | NA |
What NCT06723067 shows while recruiting
NCT06723067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 393-participant average among 38 other Premature Birth trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which Wearable wireless breast pump is the first listed.
NCT06723067 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06723067 about?
NCT06723067 is a clinical study titled "A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants". A randomized controlled trial of impact of wearable, wireless breast pumps on how often and how much milk mothers of premature infants can pump.
What is the current status of trial NCT06723067?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-06-12. Estimated completion is 2025-06.
What conditions does trial NCT06723067 study?
This clinical trial studies the following conditions: Premature Birth.
What interventions are being tested in trial NCT06723067?
The interventions under investigation include: Wearable wireless breast pump (DEVICE).
Who is sponsoring clinical trial NCT06723067?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06723067 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06723067's enrollment target sits among peer trials
30 36th of 38 higher than 3 of 38 other Premature Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
RECRUITING · NA
-
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
RECRUITING · NA
-
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI